These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Research interactions between industry and academia: a corporate perspective. Citron P Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116 [No Abstract] [Full Text] [Related]
10. Could bank loans solve Europe's biotech financing slump? Mitchell P Nat Biotechnol; 2005 Dec; 23(12):1459-60. PubMed ID: 16333276 [No Abstract] [Full Text] [Related]
11. 2007--a banner year for biotech. Lawrence S Nat Biotechnol; 2008 Feb; 26(2):150. PubMed ID: 18259162 [No Abstract] [Full Text] [Related]
13. France to focus on a few biotech clusters. Balcon E Nat Biotechnol; 2004 Sep; 22(9):1063-4. PubMed ID: 15340457 [No Abstract] [Full Text] [Related]
14. Russia through the prism of the world biopharmaceutical market. Bairamashvili DI; Rabinovich ML Biotechnol J; 2007 Jul; 2(7):801-17. PubMed ID: 17615600 [TBL] [Abstract][Full Text] [Related]
18. Public biotechnology 2005--the numbers. Lähteenmäki R; Lawrence S Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588 [TBL] [Abstract][Full Text] [Related]
19. Overcoming the challenges in the pharma/biotech industry. Graul AI; Prous JR Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900 [TBL] [Abstract][Full Text] [Related]
20. Japanese giants renew interest in industrial biotech. Sipp D Nat Biotechnol; 2005 Mar; 23(3):275-6. PubMed ID: 15765071 [No Abstract] [Full Text] [Related] [Next] [New Search]